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INTRODUCTION 
 The main 3, 4-methylenedioxymethamphetamine 
(MDMA)-induced adverse effect is disruption of normal 
thermoregulation leading to life threatening hyperthermia 
which is exacerbated by high ambient temperature and 
linked to chronic neurotoxicity [1-3]. Although the focus of 
the majority of research on MDMA-induced loss of 
thermoregulation has been on brain serotonergic and 
dopaminergic systems, results obtained from recent studies 
suggest that microglial activation and the subsequent release 
of the pyrogen interleukin-1 could also contribute to these 
effects [4, 5]. The aim of this study is to extend our 
understanding of the underlying mechanisms in the brain 
leading to the disruption of normal thermoregulation. We 
have examined the effect of interleukin 1 receptor antagonist 
(IL-1RA) on MDMA-induced hyperthermia and behavioural 
effects. 
METHODS 
 Male Sprague Dawley rats maintained at normal ambient 
temperature (22 ± 1
o
C) were administered 10 mg/kg (i.p.) of 
MDMA and core body temperature and behavioural 
measurements were taken every 30 min for 4 hours. The 
interleukin 1 receptor antagonist (IL-1RA, 40 mg/kg i.p.) 
was administered 30 min prior to MDMA administration. 
Core body temperature measurements were analysed using a 
two-way ANOVA with Bonferroni’s post-hoc test. 
Behavioural data were compared using the Kruskal-Wallis 
test. P < 0.05 was taken as significant for all analyses. 
RESULTS 
 Fig. (1) illustrates the core body temperature response for 
each treatment group. No significant changes in core body 
temperature were recorded for Saline+Saline or IL-
1RA+Saline treated rats (P > 0.05, n=5-9). After 
Saline+MDMA treatment, core body temperature increased 
by 2.4 
o
C and significant hyperthermic response was 
maintained from 30 min up to 240 min post MDMA 
compared to control group (P < 0.05, n=11). Although IL-
1RA+MDMA treated animals showed similar hyperthermic  
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response as MDMA+Saline group up to 120 min, all animals 
pre-treated with IL-1RA showed a significant decrease in 
body temperature at 180, 210 and 240 min. MDMA-treated 
animals had significantly increased behaviour scores over 
saline-only treated controls (P < 0.05, n=12). IL-1RA pre-
treatment did not produce any significant effect on MDMA-
induced behavioural effect. 
 
Fig. (1). Effect of MDMA on core body temperature, represented as 
the change from baseline temperature (mean of temperature 
recorded at -60 and -30 mins). Saline or IL-1RA was administered 
at –30 min; Saline or MDMA (10 mg/kg, i.p.) was administered at 0 
min. Data are given as mean + SEM (n = 4-12). 
DISCUSSION 
 IL-1RA pre-treatment significantly attenuated the 
magnitude and duration of hyperthermia induced by MDMA 
administration. IL-1RA pre-treatment had no significant 
impact on MDMA-induced behavioural stimulation. The 
results of this study indicate that the mechanisms underlying 
MDMA induced hyperthermia may include the release of the 
endogenous pyrogen interleukin-1 in addition to serotonin 
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and dopamine mediated hyperthermic response and 
behavioural stimulation. 
CONCLUSION 
 The present findings are consistent with the hypothesis 
that inflammatory processes play a role in MDMA induced 
adverse effects [3,5] and increase in expression of pro-
inflammatory cytokines further exacerbate and sustain the 
hyperthermia caused by MDMA. 
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